Pricing Log in Create free account

Harte Hanks, Inc. (HHS) vs Genenta Science S.p.A. Unsponsored ADR (SAEN)

Harte Hanks, Inc. and Genenta Science S.p.A. Unsponsored ADR are both Conglomerates companies. Harte Hanks, Inc. and Genenta Science S.p.A. Unsponsored ADR are of similar size ($31.3M and $29.9M). Across the 9 metrics below, Genenta Science S.p.A. Unsponsored ADR leads on 6 and Harte Hanks, Inc. on 3.

Valuation

Metric HHS SAEN Conglomerates median
P/E n/m — 10.31
P/S 0.19 — 0.61
P/B 1.92 n/m 1.14
Price to free cash flow n/m n/m 14.01
EV/EBITDA n/m n/m 10.13
EV/Sales 0.24 n/m 1.29
Earnings yield (19.14%) — 2.65%
Free cash flow yield (4.91%) 0.00% 0.00%

Profitability

Metric HHS SAEN Conglomerates median
Gross margin 16.86% — 30.27%
Operating margin (3.15%) — 3.46%
Net margin (3.70%) — 1.95%
Free cash flow margin (0.94%) 0.00% 0.00%
Return on equity (30.41%) 0.00% 0.94%
Return on assets (6.24%) 0.00% 0.06%
Return on invested capital (23.11%) 0.00% 0.73%

Growth

Metric HHS SAEN Conglomerates median
Revenue growth (TTM) (11.62%) — 6.98%
EPS growth (last fiscal year) 97.35% 30.19% 12.05%
Revenue growth, 5-year CAGR (2.04%) — 6.85%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HHS SAEN Conglomerates median
Debt to equity 0.20 0.35 0.43
Current ratio 1.30 14.16 1.47
Net debt to EBITDA (1.15) 3.12 1.17

Dividend

Metric HHS SAEN Conglomerates median
Dividend yield — — 2.77%
Payout ratio — — 0.35

Size

Metric HHS SAEN Conglomerates median
Market cap 29.85m 31.33m 422.37m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack